查看購物車
  • English
  • Japanese
  • Korean
醫療圖像分析市場－全球及區域分析：依產品類型、影像類型、顯像模式、應用、最終使用者、地區和國家分類－分析與預測，2026-2036年
市場調查報告書
商品編碼
2074804

醫療圖像分析市場－全球及區域分析：依產品類型、影像類型、顯像模式、應用、最終使用者、地區和國家分類－分析與預測，2026-2036年

Medical Image Analytics Market - A Global and Regional Analysis: Focus on Product Type, Imaging Type, Imaging Modality, Application, End User, Regional, and Country - Analysis Forecast, 2026-2036
出版日期: | 出版商: BIS Research | 英文 141 Pages | 商品交期: 1-5個工作天內

價格

全球醫療圖像分析市場在 2025 年的初始估值為 389.68 億美元，但預計到 2036 年將達到 102.367 億美元，預計從 2026 年到 2036 年將實現 9.24% 的顯著複合年成長率。

關鍵市場統計數據
預測期 2026-2036
2026 年市場規模 42.319億美元
2036年的預測 102.367億美元
複合年成長率 9.24%

全球醫療圖像分析市場已從專注於後處理和視覺化的軟體領域發展成為涵蓋臨床決策支援和工作流程實施的更廣泛的生態系統。這包括高級視覺化、2D/3D/4D影像分析、分割、抗蝕劑、融合、定量分析、電腦輔助檢測、治療計劃支援以及人工智慧驅動的影像診斷工具。這些解決方案正日益被放射學、循環系統、腫瘤學、神經科、婦產科和肌肉骨骼影像學等領域所採用，以提高診斷可靠性、簡化臨床工作流程並支持更客觀、更可重複的影像解讀。

全球醫療圖像分析市場的成長主要受以下因素驅動：影像檢查的增加、疾病負擔的加重、放射科醫生和診斷放射科醫生的短缺，以及對更快、更標準化的診斷工作流程日益成長的需求。醫院和影像中心面臨著在保證報告品質和周轉時間的同時，應對不斷成長的掃描量的壓力。因此，影像分析工具作為工作流程支援解決方案，其重要性日益凸顯，它們能夠自動化重複性任務、改善影像評估、量化疾病進展並輔助臨床決策。

整體而言，全球醫療圖像分析市場正朝著整合、擴充性且經過臨床檢驗的分析解決方案方向發展，這些解決方案既能支援常規影像工作流程，也能支援高度複雜的專業應用情境。預計在那些能夠帶來可衡量價值的領域，例如減輕工作量、提高診斷一致性、支持疾病早期檢測以及實現基於影像的定量診療路徑，此類解決方案的應用將最為廣泛。

市場概覽

醫療圖像分析正逐漸成為診斷影像生態系統中至關重要的軟體層，使醫療專業人員能夠從所擷取的影像資料中挖掘更多臨床和營運價值。隨著醫院和影像中心面臨掃描量不斷增加、疾病負擔日益加重以及放射科容量壓力不斷增大等挑戰，對能夠支持影像視覺化、量化、後處理、輔助判讀和治療計劃工作流程的解決方案的需求也日益成長。

隨著分析工具與影像設備、PACS、高級視覺化平台、企業級影像系統和雲端臨床工作流程的深度整合，全球醫療圖像分析市場正蓬勃發展。這種應用趨勢源於簡化報告、提高診斷一致性、加強疾病監測以及改善放射科、循環系統、腫瘤科、神經科和其他臨床領域特定影像工作流程的需求。隨著成熟的影像設備供應商和專業軟體公司不斷擴充性產品線，全球醫療圖像分析市場預計將轉向整合、可擴展且經過臨床檢驗的解決方案，這些解決方案不僅支援常規診斷，還能支援先進的影像導引診療路徑。

對產業的影響

全球醫療圖像分析市場競爭格局多元化，主要影像設備供應商、企業級影像公司、先進視覺化技術專家、人工智慧影像公司以及疾病特定分析供應商均參與其中。 GE醫療技術公司、西門子醫療、皇家飛利浦、富士膠片控股株式會社和Esaote SPA等領先的醫療技術公司正透過將分析功能整合到影像系統、視覺化平台、治療計畫工具和企業工作流程環境中，不斷鞏固自身市場地位。因此，影像分析正日益成為診斷影像基礎設施的核心層，而不再只是獨立的後處理功能。

同時，Aidoc、Qure.ai、Lunit Inc.、Subtle Medical、Medis Medical Imaging Systems BV、Circle Cardiovascular Imaging Inc. 和 Guerbet（Intrasense）等專業公司正透過針對特定成像模式和疾病的解決方案，加速市場發展，這些解決方案涵蓋乳房攝影篩檢成像、腫瘤學、循環系統、心臟病乳房攝影、影像學和乳房增強影像學。這些公司的策略包括獲得監管部門批准、與醫院和影像網路合作、升級產品、整合平台以及拓展區域業務。這些趨勢加劇了市場競爭，拓展了臨床應用場景，並推動市場朝向更加整合、以工作流程為中心且經過臨床檢驗的影像分析解決方案發展。

目錄

第1章：全球醫療圖像分析市場：產業展望

  • 市場趨勢
    • 影響分析
    • 從獨立的點解決方案過渡到整合的、多應用的影像分析產品組合。
    • 臨床工作流程中向定量和縱向影像分析結果的過渡
  • 監理情勢
    • 美國
    • 歐洲
    • 亞太地區
  • 市場動態
    • 促進因素、挑戰和機會：當前和未來影響評估
    • 市場促進因素
    • 市場挑戰
    • 市場機遇

第2章 產品類型

  • 獨立軟體
  • 整合軟體

第3章 影像類型

  • 2D成像
  • 3D成像
  • 4D成像

第4章 成像方式

  • X光
  • 電腦斷層掃描
  • 磁振造影
  • 超音波
  • 其他方式

第5章 應用

  • 循環系統
  • 腫瘤學
  • 神經病學
  • 婦產科
  • 整形外科
  • 其他用途

第6章 最終用戶

  • 醫院
  • 診斷影像中心
  • 其他最終用戶

第7章 區域

  • 區域概況
  • 北美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 美國
      • 加拿大
  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 英國
      • 德國
      • 法國
      • 義大利
      • 西班牙
      • 其他歐洲國家
  • 亞太地區
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳洲和紐西蘭
      • 亞太其他地區
  • 拉丁美洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測
      • 巴西
      • 墨西哥
      • 其他拉丁美洲
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 市場挑戰
    • 市場規模及預測

第8章：競爭標竿分析與公司概況

  • 關鍵策略與趨勢（2023-2026）
  • 公司重大發展動態
  • 公司簡介
    • Aidoc
    • Canon Inc.
    • Carestream Health
    • Circle Cardiovascular Imaging Inc.
    • Esaote SPA
    • GE HealthCare Technologies Inc.
    • Guerbet Group（Intrasense）
    • FUJIFILM Holdings Corporation
    • Koninklijke Philips NV
    • Lunit Inc.
    • Medis Medical Imaging Systems BV
    • MeVis Medical Solutions AG
    • Qure.ai
    • Siemens Healthineers AG
    • Subtle Medical, Inc.

第9章：調查方法

Product Code: BH00542SB

This report can be delivered within 1 working day.

Introduction of the Global Medical Image Analytics Market

The global medical image analytics market, initially valued at $3,896.8 million in 2025, is projected to grow substantially, reaching $10,236.7 million by 2036, with a remarkable compound annual growth rate (CAGR) of 9.24% from 2026 to 2036.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$4,231.9 Million
2036 Forecast$10,236.7 Million
CAGR9.24%

The global medical image analytics market has evolved from a post-processing and visualization-focused software category into a broader clinical decision support and workflow enablement ecosystem. It includes advanced visualization, 2D/3D/4D image analysis, segmentation, registration, fusion, quantitative analysis, computer-aided detection, treatment-planning support, and AI-enabled image interpretation tools. These solutions are increasingly being adopted across radiology, cardiology, oncology, neurology, obstetrics and gynecology, and musculoskeletal imaging to improve diagnostic confidence, streamline clinical workflows, and support more objective and reproducible image interpretation.

The growth of the global medical image analytics market has been supported by rising imaging procedure volumes, increasing disease burden, shortage of radiologists and imaging specialists, and growing demand for faster and more standardized diagnostic workflows. Hospitals and diagnostic imaging centers are under pressure to manage higher scan volumes while maintaining reporting quality and turnaround times. As a result, image analytics tools have gained importance as workflow-support solutions that help automate repetitive tasks, enhance image assessment, quantify disease progression, and support clinical decision-making.

Overall, the global medical image analytics market is moving toward integrated, scalable, and clinically validated analytics solutions that can support both routine imaging workflows and high-complexity specialty use cases. Adoption is expected to be strongest where solutions demonstrate measurable value in reducing workload, improving diagnostic consistency, supporting earlier disease detection, and enabling quantitative imaging-based care pathways.

Market Introduction

Medical image analytics is becoming an important software layer within the diagnostic imaging ecosystem, enabling healthcare providers to extract more clinical and operational value from acquired imaging data. As hospitals and imaging centers manage rising scan volumes, growing disease burden, and increasing pressure on radiology capacity, demand is expanding for solutions that support image visualization, quantification, post-processing, interpretation support, and treatment-planning workflows.

The global medical image analytics market is gaining momentum as analytics tools become more deeply integrated into imaging modalities, PACS, advanced visualization platforms, enterprise imaging systems, and cloud-based clinical workflows. Adoption is being driven by the need to improve reporting efficiency, diagnostic consistency, disease monitoring, and specialty imaging workflows across radiology, cardiology, oncology, neurology, and other clinical areas. With both established imaging vendors and specialized software companies expanding their portfolios, the global medical image analytics market is expected to shift toward integrated, scalable, and clinically validated solutions that support routine diagnostics as well as advanced image-guided care pathways.

Industrial Impact

The global medical image analytics market is being shaped by a mixed competitive structure that includes large imaging modality vendors, enterprise imaging companies, advanced visualization specialists, AI-native imaging companies, and disease-specific analytics providers. Large healthcare technology companies such as GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., FUJIFILM Holdings Corporation, and Esaote SPA are strengthening their position by embedding analytics within imaging systems, visualization platforms, procedure-planning tools, and enterprise workflow environments. This is increasing the role of image analytics as a core layer within diagnostic imaging infrastructure rather than a separate post-processing function.

At the same time, specialized companies such as Aidoc, Qure.ai, Lunit Inc., Subtle Medical, Medis Medical Imaging Systems B.V., Circle Cardiovascular Imaging Inc., and Guerbet (Intrasense) are accelerating market development through modality-specific and disease-focused solutions across chest imaging, oncology, neurology, cardiology, breast imaging, MRI enhancement, and advanced visualization. Their strategies include regulatory clearances, hospital and imaging-network partnerships, product upgrades, platform integrations, and regional expansion. These developments are intensifying competition, expanding clinical use cases, and pushing the market toward more integrated, workflow-oriented, and clinically validated image analytics solutions.

Market Segmentation:

Segmentation 1: By Product Type

  • Standalone Software
  • Integrated Software

Integrated Software Segment to Dominate the Global Medical Image Analytics Market (by Product Type)

In 2025, on the basis of product type, integrated software accounted for the largest share of the global medical image analytics market. Healthcare providers increasingly prefer analytics tools embedded within PACS, enterprise imaging platforms, advanced visualization systems, and modality vendor ecosystems, as these reduce workflow disruption and support faster clinical adoption. Integrated solutions also offer stronger interoperability, easier access to prior images, and smoother use across radiology reporting and treatment-planning workflows. Standalone software remains relevant for specialized use cases, although adoption is comparatively more selective due to integration and workflow-deployment requirements.

Segmentation 2: By Imaging Type

  • 2D Imaging
  • 3D Imaging
  • 4D Imaging
  • 3D Segment to Dominate the Global Medical Image Analytics Market (by Imaging Type)

In 2025, on the basis of imaging type, 3D imaging accounted for the largest share of the medical image analytics market. It has broad clinical utility across CT, MRI, ultrasound, cardiology, oncology, neurology, and surgical/treatment-planning workflows, where volumetric visualization, segmentation, fusion, and quantitative assessment are critical. Compared with 2D imaging, 3D analytics offers higher-value clinical interpretation and procedure-planning support, while 4D imaging remains more specialized and comparatively limited to select dynamic imaging.

Segmentation 3: By Imaging Modality

  • X-Ray
  • Ultrasound
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Others

Computed Tomography Segment to Dominate the Global Medical Image Analytics Market (by Imaging Modality)

In 2025, on the basis of imaging modality, computed tomography accounted for the largest share of the medical image analytics market. CT generates high-volume, high-complexity image datasets that require advanced visualization, 3D reconstruction, segmentation, lesion detection, vessel analysis, and quantitative assessment. Its strong use across oncology, cardiology, neurology, emergency care, and surgical planning creates broad demand for analytics software. X-ray has a higher procedure volume, although CT typically drives greater analytics value per study due to richer image complexity and wider use in advanced clinical decision-making.

Segmentation 4: By Application

  • Cardiology
  • Oncology
  • Neurology
  • Obstetrics and Gynecology
  • Orthopedics
  • Other Applications

Oncology Segment to Dominate the Global Medical Image Analytics Market (by Application)

In 2025, on the basis of application, oncology accounted for the largest share of the medical image analytics market. The segment has strong demand for lesion detection, tumor segmentation, staging, treatment-planning support, response assessment, and longitudinal disease monitoring across CT, MRI, PET/CT, ultrasound, and X-ray workflows. Rising cancer screening volumes and the growing use of quantitative imaging in precision oncology further increase the need for analytics tools. Cardiology remains a major application area, while oncology offers broader cross-modality usage and a higher need for continuous image-based assessment.

Segmentation 5: By End User

  • Hospitals
  • Diagnostics Imaging Centers
  • Other End Users

Hospitals Segment to Dominate the Medical Image Analytics Market (by End User)

In 2025, on the basis of end user, hospitals account for the largest share of the medical image analytics market. They handle the highest volume and complexity of imaging cases across emergency care, oncology, cardiology, neurology, orthopedics, and surgical planning, creating broad demand for advanced analytics. Hospitals also have stronger budgets, integrated PACS/enterprise imaging infrastructure, and a greater need for workflow optimization across multiple departments. Diagnostic imaging centers remain important, although their adoption is comparatively more concentrated around high-throughput outpatient imaging and screening workflows.

Segmentation 6: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia and New Zealand
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

North America to Dominate the Medical Image Analytics Market (by Region)

In 2025, North America accounted for the largest share of the global medical image analytics market. The region benefits from high imaging procedure volumes, strong adoption of advanced visualization and AI-enabled analytics, mature hospital IT infrastructure, and early regulatory clearance of imaging software solutions. The U.S. also has a high concentration of leading vendors, active clinical AI deployment across large health systems, and stronger purchasing capacity among hospitals and imaging networks. These factors make North America the most commercially mature and scalable market for medical image analytics solutions.

Recent Developments in the Medical Image Analytics Market

  • In May 2026, Pie Medical Imaging expanded its Utrecht office by 50% to support the growing team behind its structural heart disease management solutions. The expansion reflected increasing global adoption of the 3mensio product line and reinforced the company's investment in cardiovascular image analysis, visualization, and procedure-planning innovation.
  • In April 2026, Sol Radiology partnered with Aidoc to deploy a suite of FDA-cleared, multi-condition clinical AI solutions across hospitals, outpatient imaging centers, and urgent care facilities in Southern California. The collaboration aimed to improve critical finding prioritization, accelerate communication with referring physicians, and enhance radiology workflow efficiency.
  • In February 2026, Qure.ai received U.S. FDA 510(k) Class II clearance for qXR-Detect, its AI-powered chest X-ray CADe solution covering six key regions of interest. The clearance strengthened Qure.ai's U.S. radiology AI portfolio and supported broader use of AI for early abnormality detection, localization, and clinical workflow support in chest radiography.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Rising Disease Burden Driving Higher Demand for Advanced Imaging and Image Analytics: The rising burden of imaging-intensive diseases such as cancer, cardiovascular diseases, stroke, COPD, and neurological disorders is expanding the need for advanced diagnostic imaging and follow-up assessment. As these conditions often require CT, MRI, PET, ultrasound, or X-ray across diagnosis, staging, monitoring, and treatment planning, healthcare systems are facing sustained growth in imaging volumes. This creates a stronger need for image analytics solutions that can improve interpretation efficiency, support earlier detection, reduce reporting burden, and enable more consistent clinical decision-making across high-volume care pathways.

Growing Radiologist Workload and Shortage of Image Interpretation Capacity Driving Adoption of Workflow Automation and Image Analytics: The widening gap between imaging demand and radiologist capacity is shifting image analytics from a value-added tool to an operational necessity. As radiology departments face growing reporting backlogs, rising case complexity, and dependence on outsourcing, providers are likely to prioritize solutions that improve throughput without compromising diagnostic quality. However, the adoption focus will increasingly move from standalone AI algorithms to workflow-integrated analytics that reduce manual effort, support prioritization, and fit seamlessly into existing PACS/RIS environments. Vendors that can demonstrate measurable efficiency gains, lower reporting burden, and smooth clinical integration are expected to see stronger adoption and growth in the foreseeable future.

Existing Installed Base of Digital Imaging Infrastructure Enabling Scalable Adoption of Image Analytics: The existing digital imaging installed base is reducing adoption friction for medical image analytics, as providers can enhance current workflows through software-led upgrades rather than major infrastructure replacement. This makes analytics adoption more scalable and commercially viable across hospitals and diagnostic imaging centers. The ability to integrate outputs such as measurements, segmentations, annotations, and derived images into existing PACS and enterprise imaging environments strengthens routine clinical usability. Vendors offering interoperable, workflow-native solutions are likely to gain stronger traction, as providers increasingly prioritize tools that improve the value of existing imaging assets while minimizing operational disruption.

Market Challenges:

Limited Availability of High-Quality Ground-Truth Data Increasing Algorithm Development and Validation Burden: The scarcity of high-quality ground-truth data creates a structural bottleneck for medical image analytics vendors, particularly in complex applications such as segmentation, contouring, registration, and treatment planning. As performance expectations rise, vendors must invest heavily in expert annotation, quality control, and larger validation datasets, increasing development timelines and commercialization costs. This challenge is likely to be more pronounced in advanced and specialty applications where annotated datasets are harder to generate and standardize. Companies with scalable annotation workflows, strong clinical partnerships, and robust validation infrastructure are better positioned to commercialize reliable image analytics solutions.

Limited Clinical Validation, Generalizability, and Trust in Image Analytics Outputs: The adoption of medical image analytics will depend less on algorithm availability and more on clinical trust in real-world performance. Evidence of performance variability across sites, devices, protocols, and patient groups suggests that providers will remain cautious unless vendors can demonstrate consistent outcomes beyond controlled validation settings. Primary survey feedback further indicates that end users are more comfortable with AI as an assistive layer than as an autonomous decision-maker. As a result, solutions with transparent validation, subgroup-level performance evidence, and clear human-in-the-loop workflows are likely to gain stronger clinical acceptance.

Market Opportunities:

Strategic Partnerships with Hospitals, Radiology Networks, and Imaging Service Providers Creating Scalable Adoption Pathways: Partnership-led commercialization is becoming a practical route for medical image analytics vendors to move from limited deployments to network-level adoption. By aligning with hospitals, imaging chains, and teleradiology providers, vendors can access larger imaging volumes, validate workflow value across diverse settings, and reduce reliance on fragmented direct sales. This model is especially relevant for smaller and mid-sized vendors that need faster market access and stronger clinical credibility. Over time, vendors with scalable partnership models and solutions that fit into multi-site workflows are likely to achieve broader adoption and stronger competitive positioning.

How can this report add value to an organization?

Product/Innovation Strategy: The global medical image analytics market has been segmented across product type, imaging type, imaging modality, application, end user, and region. This segmentation helps organizations understand the relative demand for standalone and integrated software, as well as the adoption of analytics solutions across 2D, 3D, and 4D imaging workflows. By evaluating modality-level opportunities across CT, MRI, X-ray, ultrasound, and other imaging areas, the report supports product planning, feature prioritization, workflow integration, and application-specific solution development.

Growth/Marketing Strategy: The global medical image analytics market is being driven by increasing imaging volumes, rising demand for efficient diagnostic workflows, growing use of advanced visualization tools, and the need to improve consistency in image assessment and reporting. This report helps organizations assess market entry opportunities, prioritize target customer groups, and develop growth strategies across hospitals, diagnostic imaging centers, and enterprise imaging platforms.

Competitive Strategy: The global medical image analytics market includes established imaging companies, healthcare IT vendors, and specialized software providers offering solutions across image visualization, analysis, quantification, workflow support, and modality-specific applications. The report helps organizations benchmark competitor presence, assess product positioning, identify gaps across modalities and applications, and evaluate opportunities for partnerships, acquisitions, and portfolio expansion. It also supports competitive decision-making by outlining how vendors are differentiating through software integration, clinical usability, deployment models, regulatory progress, and coverage across key imaging workflows.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for the global medical image analytics market. For market size estimation, 2025 has been considered the base year, and 2026 to 2036 the forecast period.
  • Data on the portability type was considered from national and international organizations.
  • Publicly traded companies are involved in the development of medical image analytics solutions.
  • Industry research papers, patents, and advancements in related technologies highlighted emerging trends and growth opportunities in the market. Proxy indicators were employed where direct data were unavailable.
  • Databases such as Bloomberg and governmental statistical portals offering insights on raw material usage, innovative technologies, and market trends were extensively utilized.
  • Technologies currently used are expected to persist through the forecast period 2026-2036.
  • The economic downturn in the future was not taken into consideration for market estimation and forecast.

Primary Research

The primary sources involve industry experts and key stakeholders across the healthcare and medical imaging ecosystem, including medical image analytics providers, medical device manufacturers, radiology service providers, and healthcare institutions. Stakeholders such as hospitals, imaging centers, and teleradiology providers have been consulted to validate adoption trends and clinical utility. Respondents, including CEOs, vice presidents, product and marketing directors, and technology and innovation leaders, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Aidoc
  • Canon Inc.
  • Carestream Health
  • Circle Cardiovascular Imaging Inc.
  • Esaote SpA
  • GE HealthCare Technologies Inc.
  • Guerbet Group (Intrasense)
  • FUJIFILM Holdings Corporation
  • Koninklijke Philips N.V.
  • Lunit Inc.
  • Medis Medical Imaging Systems B.V.
  • MeVis Medical Solutions AG
  • Qure.ai
  • Siemens Healthineers AG
  • Subtle Medical, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Global Medical Image Analytics Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Impact Analysis
    • 1.1.2 Shift from Standalone Point Solutions toward Integrated Multi-Application Image Analytics Portfolios
    • 1.1.3 Shift toward Quantitative and Longitudinal Imaging Outputs in Clinical Workflows
  • 1.2 Regulatory Landscape
    • 1.2.1 U.S.
    • 1.2.2 Europe
    • 1.2.3 Asia-Pacific
      • 1.2.3.1 China
      • 1.2.3.2 Japan
  • 1.3 Market Dynamics
    • 1.3.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 1.3.2 Market Drivers
      • 1.3.2.1 Rising Disease Burden Driving Higher Demand for Advanced Imaging and Image Analytics
      • 1.3.2.2 Growing Radiologist Workload and Shortage of Image Interpretation Capacity Driving Adoption of Workflow Automation and Image Analytics
      • 1.3.2.3 Existing Installed Base of Digital Imaging Infrastructure Enabling Scalable Adoption of Image Analytics
    • 1.3.3 Market Challenges
      • 1.3.3.1 Limited Availability of High-Quality Ground-Truth Data Increasing Algorithm Development and Validation Burden
      • 1.3.3.2 Limited Clinical Validation, Generalizability, and Trust in Image Analytics Outputs
    • 1.3.4 Market Opportunities
      • 1.3.4.1 Strategic Partnerships with Hospitals, Radiology Networks, and Imaging Service Providers Creating Scalable Adoption Pathways

2 Product Type

  • 2.1 Standalone Software
  • 2.2 Integrated Software

3 Imaging Type

  • 3.1 2D Imaging
  • 3.2 3D Imaging
  • 3.3 4D Imaging

4 Imaging Modality

  • 4.1 X-Ray
  • 4.2 Computed Tomography
  • 4.3 Magnetic Resonance Imaging
  • 4.4 Ultrasound
  • 4.5 Other Modalities

5 Application

  • 5.1 Cardiology
  • 5.2 Oncology
  • 5.3 Neurology
  • 5.4 Obstetrics and Gynecology
  • 5.5 Orthopedics
  • 5.6 Other Applications

6 End User

  • 6.1 Hospitals
  • 6.2 Diagnostics Imaging Centers
  • 6.3 Other End Users

7 Region

  • 7.1 Regional Summary
  • 7.2 North America
    • 7.2.1 Regional Overview
    • 7.2.2 Driving Factors for Market Growth
    • 7.2.3 Factors Challenging the Market
    • 7.2.4 Market Sizing and Forecast
      • 7.2.4.1 U.S.
        • 7.2.4.1.1 Country Overview
        • 7.2.4.1.2 Driving Factors for Market Growth
        • 7.2.4.1.3 Factors Challenging the Market
        • 7.2.4.1.4 Market Sizing and Forecast
      • 7.2.4.2 Canada
        • 7.2.4.2.1 Country Overview
        • 7.2.4.2.2 Driving Factors for Market Growth
        • 7.2.4.2.3 Factors Challenging the Market
        • 7.2.4.2.4 Market Sizing and Forecast
  • 7.3 Europe
    • 7.3.1 Regional Overview
    • 7.3.2 Driving Factors for Market Growth
    • 7.3.3 Factors Challenging the Market
    • 7.3.4 Market Sizing and Forecast
      • 7.3.4.1 U.K.
        • 7.3.4.1.1 Country Overview
        • 7.3.4.1.2 Driving Factors for Market Growth
        • 7.3.4.1.3 Factors Challenging the Market
        • 7.3.4.1.4 Market Sizing and Forecast
      • 7.3.4.2 Germany
        • 7.3.4.2.1 Country Overview
        • 7.3.4.2.2 Driving Factors for Market Growth
        • 7.3.4.2.3 Factors Challenging the Market
        • 7.3.4.2.4 Market Sizing and Forecast
      • 7.3.4.3 France
        • 7.3.4.3.1 Country Overview
        • 7.3.4.3.2 Driving Factors for Market Growth
        • 7.3.4.3.3 Factors Challenging the Market
        • 7.3.4.3.4 Market Sizing and Forecast
      • 7.3.4.4 Italy
        • 7.3.4.4.1 Country Overview
        • 7.3.4.4.2 Driving Factors for Market Growth
        • 7.3.4.4.3 Factors Challenging the Market
        • 7.3.4.4.4 Market Sizing and Forecast
      • 7.3.4.5 Spain
        • 7.3.4.5.1 Country Overview
        • 7.3.4.5.2 Driving Factors for Market Growth
        • 7.3.4.5.3 Factors Challenging the Market
        • 7.3.4.5.4 Market Sizing and Forecast
      • 7.3.4.6 Rest-of-Europe
        • 7.3.4.6.1 Country Overview
        • 7.3.4.6.2 Driving Factors for Market Growth
        • 7.3.4.6.3 Factors Challenging the Market
        • 7.3.4.6.4 Market Sizing and Forecast
  • 7.4 Asia Pacific
    • 7.4.1 Regional Overview
    • 7.4.2 Driving Factors for Market Growth
    • 7.4.3 Factors Challenging the Market
    • 7.4.4 Market Sizing and Forecast
      • 7.4.4.1 China
        • 7.4.4.1.1 Country Overview
        • 7.4.4.1.2 Driving Factors for Market Growth
        • 7.4.4.1.3 Factors Challenging the Market
        • 7.4.4.1.4 Market Sizing and Forecast
      • 7.4.4.2 Japan
        • 7.4.4.2.1 Country Overview
        • 7.4.4.2.2 Driving Factors for Market Growth
        • 7.4.4.2.3 Factors Challenging the Market
        • 7.4.4.2.4 Market Sizing and Forecast
      • 7.4.4.3 India
        • 7.4.4.3.1 Country Overview
        • 7.4.4.3.2 Driving Factors for Market Growth
        • 7.4.4.3.3 Factors Challenging the Market
        • 7.4.4.3.4 Market Sizing and Forecast
      • 7.4.4.4 South Korea
        • 7.4.4.4.1 Country Overview
        • 7.4.4.4.2 Driving Factors for Market Growth
        • 7.4.4.4.3 Factors Challenging the Market
        • 7.4.4.4.4 Market Sizing and Forecast
      • 7.4.4.5 Australia and New Zealand
        • 7.4.4.5.1 Country Overview
        • 7.4.4.5.2 Driving Factors for Market Growth
        • 7.4.4.5.3 Factors Challenging the Market
        • 7.4.4.5.4 Market Sizing and Forecast
      • 7.4.4.6 Rest-of-Asia Pacific
        • 7.4.4.6.1 Country Overview
        • 7.4.4.6.2 Driving Factors for Market Growth
        • 7.4.4.6.3 Factors Challenging the Market
        • 7.4.4.6.4 Market Sizing and Forecast
  • 7.5 Latin America
    • 7.5.1 Regional Overview
    • 7.5.2 Driving Factors for Market Growth
    • 7.5.3 Factors Challenging the Market
    • 7.5.4 Market Sizing and Forecast
      • 7.5.4.1 Brazil
        • 7.5.4.1.1 Country Overview
        • 7.5.4.1.2 Driving Factors for Market Growth
        • 7.5.4.1.3 Factors Challenging the Market
        • 7.5.4.1.4 Market Sizing and Forecast
      • 7.5.4.2 Mexico
        • 7.5.4.2.1 Country Overview
        • 7.5.4.2.2 Driving Factors for Market Growth
        • 7.5.4.2.3 Factors Challenging the Market
        • 7.5.4.2.4 Market Sizing and Forecast
      • 7.5.4.3 Rest-of-Latin America
        • 7.5.4.3.1 Country Overview
        • 7.5.4.3.2 Driving Factors for Market Growth
        • 7.5.4.3.3 Factors Challenging the Market
        • 7.5.4.3.4 Market Sizing and Forecast
  • 7.6 Middle East and Africa
    • 7.6.1 Regional Overview
    • 7.6.2 Driving Factors for Market Growth
    • 7.6.3 Factors Challenging the Market
    • 7.6.4 Market Sizing and Forecast

8 Competitive Benchmarking and Company Profiles

  • 8.1 Key Strategies and Developments, 2023-2026
  • 8.2 Key Developments (by Company)
  • 8.3 Company Profiles
    • 8.3.1 Aidoc
      • 8.3.1.1 Overview
      • 8.3.1.2 Top Products
      • 8.3.1.3 Top Competitors
      • 8.3.1.4 Key Personnel
      • 8.3.1.5 Analyst View
    • 8.3.2 Canon Inc.
      • 8.3.2.1 Overview
      • 8.3.2.2 Top Products
      • 8.3.2.3 Top Competitors
      • 8.3.2.4 Key Personnel
      • 8.3.2.5 Analyst View
    • 8.3.3 Carestream Health
      • 8.3.3.1 Overview
      • 8.3.3.2 Top Products
      • 8.3.3.3 Top Competitors
      • 8.3.3.4 Key Personnel
      • 8.3.3.5 Analyst View
    • 8.3.4 Circle Cardiovascular Imaging Inc.
      • 8.3.4.1 Overview
      • 8.3.4.2 Top Products
      • 8.3.4.3 Top Competitors
      • 8.3.4.4 Key Personnel
      • 8.3.4.5 Analyst View
    • 8.3.5 Esaote SPA
      • 8.3.5.1 Overview
      • 8.3.5.2 Top Products
      • 8.3.5.3 Top Competitors
      • 8.3.5.4 Key Personnel
      • 8.3.5.5 Analyst View
    • 8.3.6 GE HealthCare Technologies Inc.
      • 8.3.6.1 Overview
      • 8.3.6.2 Top Products
      • 8.3.6.3 Top Competitors
      • 8.3.6.4 Key Personnel
      • 8.3.6.5 Analyst View
    • 8.3.7 Guerbet Group (Intrasense)
      • 8.3.7.1 Overview
      • 8.3.7.2 Top Products
      • 8.3.7.3 Top Competitors
      • 8.3.7.4 Key Personnel
      • 8.3.7.5 Analyst View
    • 8.3.8 FUJIFILM Holdings Corporation
      • 8.3.8.1 Overview
      • 8.3.8.2 Top Products
      • 8.3.8.3 Top Competitors
      • 8.3.8.4 Key Personnel
      • 8.3.8.5 Analyst View
    • 8.3.9 Koninklijke Philips N.V.
      • 8.3.9.1 Overview
      • 8.3.9.2 Top Products
      • 8.3.9.3 Top Competitors
      • 8.3.9.4 Key Personnel
      • 8.3.9.5 Analyst View
    • 8.3.10 Lunit Inc.
      • 8.3.10.1 Overview
      • 8.3.10.2 Top Products
      • 8.3.10.3 Top Competitors
      • 8.3.10.4 Key Personnel
      • 8.3.10.5 Analyst View
    • 8.3.11 Medis Medical Imaging Systems B.V.
      • 8.3.11.1 Overview
      • 8.3.11.2 Top Products
      • 8.3.11.3 Top Competitors
      • 8.3.11.4 Key Personnel
      • 8.3.11.5 Analyst View
    • 8.3.12 MeVis Medical Solutions AG
      • 8.3.12.1 Overview
      • 8.3.12.2 Top Products
      • 8.3.12.3 Top Competitors
      • 8.3.12.4 Key Personnel
      • 8.3.12.5 Analyst View
    • 8.3.13 Qure.ai
      • 8.3.13.1 Overview
      • 8.3.13.2 Top Products
      • 8.3.13.3 Top Competitors
      • 8.3.13.4 Key Personnel
      • 8.3.13.5 Analyst View
    • 8.3.14 Siemens Healthineers AG
      • 8.3.14.1 Overview
      • 8.3.14.2 Top Products
      • 8.3.14.3 Top Competitors
      • 8.3.14.4 Key Personnel
      • 8.3.14.5 Analyst View
    • 8.3.15 Subtle Medical, Inc.
      • 8.3.15.1 Overview
      • 8.3.15.2 Top Products
      • 8.3.15.3 Top Competitors
      • 8.3.15.4 Key Personnel
      • 8.3.15.5 Analyst View

9 Research Methodology

  • 9.1 Data Sources
    • 9.1.1 Primary Data Sources
    • 9.1.2 Secondary Data Sources
    • 9.1.3 Data Triangulation
  • 9.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Medical Image Analytics Market (by Scenario), $Million, 2024, 2030, and 2036
  • Figure 2: Global Medical Image Analytics Market, $Million, 2025, 2030, and 2036
  • Figure 3: Medical Image Analytics Market (by Product Type), $Million, 2025, 2030, and 2036
  • Figure 4: Medical Image Analytics Market (by Imaging Type), $Million, 2025, 2030, and 2036
  • Figure 5: Medical Image Analytics Market (by Imaging Modality), $Million, 2025, 2030, and 2036
  • Figure 6: Medical Image Analytics Market (by Application), $Million, 2025, 2030, and 2036
  • Figure 7: Medical Image Analytics Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 8: Global Medical Image Analytics Market (by Product Type), $Million, 2025, 2030, and 2036
  • Figure 9: Global Medical Image Analytics Market (Standalone Software), $Million, 2024-2036
  • Figure 10: Global Medical Image Analytics Market (Integrated Software), $Million, 2024-2036
  • Figure 11: Global Medical Image Analytics Market (by Imaging Type), $Million, 2025, 2030, and 2036
  • Figure 12: Global Medical Image Analytics Market (2D Imaging), $Million, 2024-2036
  • Figure 13: Global Medical Image Analytics Market (3D Imaging), $Million, 2024-2036
  • Figure 14: Global Medical Image Analytics Market (4D Imaging), $Million, 2024-2036
  • Figure 15: Global Medical Image Analytics Market (by Imaging Modality), $Million, 2025, 2030, and 2036
  • Figure 16: Global Medical Image Analytics Market (X-Ray), $Million, 2024-2036
  • Figure 17: Global Medical Image Analytics Market (Computed Tomography), $Million, 2024-2036
  • Figure 18: Global Medical Image Analytics Market (Magnetic Resonance Imaging), $Million, 2024-2036
  • Figure 19: Global Medical Image Analytics Market (Ultrasound), $Million, 2024-2036
  • Figure 20: Global Medical Image Analytics Market (Other Modalities), $Million, 2024-2036
  • Figure 21: Global Medical Image Analytics Market (by Application), $Million, 2025, 2030, and 2036
  • Figure 22: Global Medical Image Analytics Market (Cardiology), $Million, 2024-2036
  • Figure 23: Global Medical Image Analytics Market (Oncology), $Million, 2024-2036
  • Figure 24: Global Medical Image Analytics Market (Neurology), $Million, 2024-2036
  • Figure 25: Global Medical Image Analytics Market (Obstetrics and Gynecology), $Million, 2024-2036
  • Figure 26: Global Medical Image Analytics Market (Orthopedics), $Million, 2024-2036
  • Figure 27: Global Medical Image Analytics Market (Other Applications), $Million, 2024-2036
  • Figure 28: Global Medical Image Analytics Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 29: Global Medical Image Analytics Market (Hospitals), $Million, 2024-2036
  • Figure 30: Global Medical Image Analytics Market (Diagnostics Imaging Centers), $Million, 2024-2036
  • Figure 31: Global Medical Image Analytics Market (Other End Users), $Million, 2024-2036
  • Figure 32: North America Medical Image Analytics Market, $Million, 2024-2036
  • Figure 33: U.S. Medical Image Analytics Market, $Million, 2024-2036
  • Figure 34: Canada Medical Image Analytics Market, $Million, 2024-2036
  • Figure 35: Europe Medical Image Analytics Market, $Million, 2024-2036
  • Figure 36: U.K. Medical Image Analytics Market, $Million, 2024-2036
  • Figure 37: Germany Medical Image Analytics Market, $Million, 2024-2036
  • Figure 38: France Medical Image Analytics Market, $Million, 2024-2036
  • Figure 39: Italy Medical Image Analytics Market, $Million, 2024-2036
  • Figure 40: Spain Medical Image Analytics Market, $Million, 2024-2036
  • Figure 41: Rest-of-Europe Medical Image Analytics Market, $Million, 2024-2036
  • Figure 42: Asia-Pacific Medical Image Analytics Market, $Million, 2024-2036
  • Figure 43: China Medical Image Analytics Market, $Million, 2024-2036
  • Figure 44: Japan Medical Image Analytics Market, $Million, 2024-2036
  • Figure 45: India Medical Image Analytics Market, $Million, 2024-2036
  • Figure 46: South Korea Medical Image Analytics Market, $Million, 2024-2036
  • Figure 47: Australia and New Zealand Medical Image Analytics Market, $Million, 2024-2036
  • Figure 48: Rest-of-Asia-Pacific Medical Image Analytics Market, $Million, 2024-2036
  • Figure 49: Latin America Medical Image Analytics Market, $Million, 2024-2036
  • Figure 50: Brazil Medical Image Analytics Market, $Million, 2024-2036
  • Figure 51: Mexico Medical Image Analytics Market, $Million, 2024-2036
  • Figure 52: Rest-of-Latin America Medical Image Analytics Market, $Million, 2024-2036
  • Figure 53: Middle East and Africa Medical Image Analytics Market, $Million, 2024-2036
  • Figure 54: Key Strategies and Developments, 2023-2026
  • Figure 55: Data Triangulation
  • Figure 56: Top-Down and Bottom-Up Approach
  • Figure 57: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Some of the Key Partnerships and Collaborations
  • Table 3: Global Medical Image Analytics Market (by Region), $Million, 2024-2036
  • Table 4: Some of the Key Strategies and Developments, 2023-2026